Shares of Sernova Corp. (TSE:SVA – Get Free Report) dropped 4.5% on Friday . The company traded as low as C$0.21 and last traded at C$0.21. Approximately 56,087 shares were traded during trading, a decline of 64% from the average daily volume of 157,444 shares. The stock had previously closed at C$0.22.
Sernova Price Performance
The business has a fifty day simple moving average of C$0.23 and a two-hundred day simple moving average of C$0.25. The company has a current ratio of 0.32, a quick ratio of 18.11 and a debt-to-equity ratio of 16.55. The stock has a market cap of C$68.32 million, a PE ratio of -1.62 and a beta of 1.35.
Sernova Company Profile
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.
Featured Articles
- Five stocks we like better than Sernova
- Why Invest in 5G? How to Invest in 5G Stocks
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- What Are Treasury Bonds?
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- What Do S&P 500 Stocks Tell Investors About the Market?
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.
